Mitchell Machtay

Also affiliated with University of Hong Kong - Shenzhen Hospital, NRG Oncology, University of Pennsylvania, Penn State Milton S. Hershey Medical Center, University of Hong Kong

Physics and AstronomyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer”.

Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer

Journal of Clinical Oncology(2024)10.1200/jco.24.00022

N/A

1.1DataRank · unranked

39 citations

Chen Hu, Daniel A. Pryma, Fenghai Duan, M.M. Matuszak, Ying Xiao +22 more

Embracing the Future of Clinical Trials in Radiation Therapy: An NRG Oncology CIRO Technology Retreat Whitepaper on Pioneering Technologies and AI-Driven Solutions

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.01.006

N/A

0DataRank · unranked

6 citations

Stanley R. Benedict, Yunfeng Cui, Carri Glide‐Hurst, Stephen Graves, Xun Jia +21 more